Corcept Therapeutics, Inc. (NASDAQ:CORT)

CAPS Rating: 2 out of 5

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

Recs

0
Player Avatar Fiskhus (72.87) Submitted: 2/4/2011 8:21:30 PM : Outperform Start Price: $4.15 CORT Score: -3.15

MB7 Z3

Report this Post Reply

Featured Broker Partners


Advertisement